Literature DB >> 10155262

Applying the Australian guidelines for the reimbursement of pharmaceuticals.

M Aristides1, A Mitchell.   

Abstract

Mesh:

Year:  1994        PMID: 10155262     DOI: 10.2165/00019053-199406030-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  2 in total

1.  Indirect costs in economic studies: confronting the confusion.

Authors:  M A Koopmanschap; F F Rutten
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

2.  Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.

Authors:  D Henry
Journal:  Pharmacoeconomics       Date:  1992-01       Impact factor: 4.981

  2 in total
  3 in total

1.  A reappraisal of economic evaluation of pharmaceuticals. Science or marketing?

Authors:  M F Drummond
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

Review 2.  Economic evaluation of drugs and its potential uses in policy making.

Authors:  M Johannesson
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

Review 3.  The generalisability of pharmacoeconomic studies.

Authors:  J Mason
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.